218 related articles for article (PubMed ID: 24148690)
1. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.
Yang T; Peng R; Guo Y; Shen L; Zhao S; Xu D
Lipids Health Dis; 2013 Oct; 12():151. PubMed ID: 24148690
[TBL] [Abstract][Full Text] [Related]
2. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
3. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
4. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
[TBL] [Abstract][Full Text] [Related]
5. A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.
Duflot T; Pereira T; Roche C; Iacob M; Cardinael P; Hamza NE; Thuillez C; Compagnon P; Joannidès R; Lamoureux F; Bellien J
Anal Bioanal Chem; 2017 Mar; 409(7):1845-1855. PubMed ID: 27981341
[TBL] [Abstract][Full Text] [Related]
6. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.
Akasaka T; Sueta D; Arima Y; Tabata N; Takashio S; Izumiya Y; Yamamoto E; Yamamuro M; Tsujita K; Kojima S; Kaikita K; Kajiwara A; Morita K; Oniki K; Saruwatari J; Nakagawa K; Ogata Y; Matsui K; Hokimoto S
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1409-H1415. PubMed ID: 27663770
[TBL] [Abstract][Full Text] [Related]
8. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
Karkhanis A; Tram NDT; Chan ECY
Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
[TBL] [Abstract][Full Text] [Related]
9. Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells.
Abukhashim M; Wiebe GJ; Seubert JM
Cell Biol Toxicol; 2011 Oct; 27(5):321-32. PubMed ID: 21519968
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
[TBL] [Abstract][Full Text] [Related]
11. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle.
Fang X; Kaduce TL; Weintraub NL; VanRollins M; Spector AA
Circ Res; 1996 Oct; 79(4):784-93. PubMed ID: 8831502
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Remnant Lipoprotein Cholesterol and Oxidized Low density Lipoprotein Associated with Low-grade Inflammation in Coronary Heart Disease Subjects of Young South Indian Population.
Jaishankar T; Shivasekar M; Vinodhini VM
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702834
[TBL] [Abstract][Full Text] [Related]
14. The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
Dai W; Li Y; Lv YN; Wei CD; Zheng HY
Atherosclerosis; 2014 Apr; 233(2):661-665. PubMed ID: 24561551
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
17. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
18. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
Campbell WB; Deeter C; Gauthier KM; Ingraham RH; Falck JR; Li PL
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1656-64. PubMed ID: 11959628
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.
Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
Circ Res; 1997 Aug; 81(2):258-67. PubMed ID: 9242187
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
